Sign in

Jeffrey Hanson

Non-Executive Chairman at American Healthcare REIT
Board

About Jeffrey T. Hanson

Jeffrey T. Hanson (age 54) is Non-Executive Chairman of American Healthcare REIT, Inc. (AHR). He has served on AHR’s board since 2015, was CEO and Chairman from 2015–2021, Executive Chairman from Oct 2021–Jun 2022, and Non-Executive Chairman since Jun 2022. He holds a B.S. in Business (Real Estate Finance) from USC and brings deep healthcare real estate leadership experience, including CEO roles at Griffin-American Healthcare REIT II and III and senior executive roles at Grubb & Ellis and American Healthcare Investors (AHI) .

Past Roles

OrganizationRoleTenureCommittees/Impact
American Healthcare REIT, Inc.CEO & ChairmanJan 2015–Oct 2021Led company strategy and operations
American Healthcare REIT, Inc.Executive ChairmanOct 2021–Jun 2022Transitioned leadership; board oversight
American Healthcare REIT, Inc.Non-Executive ChairmanJun 2022–presentPresides over non-management executive sessions
Griffin-American Healthcare REIT III, Inc.CEO & ChairmanJan 2013–Oct 2021Healthcare REIT leadership
Griffin-American Healthcare REIT II, Inc.CEO & ChairmanJan 2009–Dec 2014Healthcare REIT leadership
American Healthcare Investors (AHI)Founding Principal & Managing DirectorDec 2014–Oct 2021Co-sponsor; adviser ownership; investment mgmt
Grubb & Ellis CompanyEVP, Investment Programs; CIO roles2006–2011 (EVP 2007–2011)Institutional real estate investments

External Roles

OrganizationRoleTenure
Trilogy Investors, LLCDirectorDec 2015–Nov 2016

Board Governance

  • Independence: Hanson is not an independent director; AHR’s independent directors are Estes, Flornes, Hurley, O’Quinn, Richardson, and Smith .
  • Committee assignments: None; all standing committees (Audit; Compensation; Nominating & Corporate Governance) are fully independent (chairs: Estes, Hurley, Flornes) .
  • Attendance: Board held 9 meetings in FY2024; each incumbent director attended at least 75% of board and applicable committee meetings; all directors attended the most recent annual meeting .
  • Leadership: AHR separates Chair and CEO roles; there is no Lead Independent Director. Non-management executive sessions are held at least annually and presided over by Hanson (a non-management director) .

Fixed Compensation

Component (2024)Amount
Cash fees (annual retainer and applicable chair fees)$185,000
All other compensation (distributions on stock awards)$8,580
Total cash + distributions$193,580

Committee fee framework: Lead Independent Director $100,000; Audit Chair $20,000 (members $5,000); Compensation Chair $12,500; Nominating & Corporate Governance Chair $12,500 (no member fees) .

Performance Compensation

Equity AwardSharesGrant DateVestingGrant Date Fair Value
Listing Equity Award (Restricted Stock)7,407Feb 9, 202425% per year over 4 years (time-based)$192,159
Non-vested restricted stock outstanding (as of 12/31/2024)11,017Time-based vesting
  • No director performance metrics were disclosed for equity; Listing Equity Awards vest solely on continued service (time-based) .

Other Directorships & Interlocks

TypeDetail
External public company boardsNo current public company directorships disclosed in the proxy for Hanson .
Affiliated interestsAHI Group Holdings (co-founded/owned) held 1,268,643 OP Units; voting/investment determinations for these securities are made by Danny Prosky, Jeffrey T. Hanson, and Mathieu B. Streiff (shared beneficial ownership) .
Committee leadership interlocksHanson presides executive sessions though not independent; no Lead Independent Director .

Expertise & Qualifications

  • Healthcare REIT leadership (CEO/Chair of GAHR II & III) and investment management (AHI, Grubb & Ellis) .
  • Real estate finance, acquisitions, operations, capital markets relationships, and governance oversight .
  • Education: B.S., USC (Real Estate Finance) .

Equity Ownership

HolderCommon SharesOP Units% of Shares OutstandingPledged
Jeffrey T. Hanson124,9191,268,643 (via AHI Group Holdings; shared beneficial ownership with Prosky and Streiff)<1.0%None of the above shares pledged
  • AHR has NYSE-based corporate governance guidelines including minimum stock ownership requirements for directors and officers; hedging and pledging of AHR securities by directors is prohibited under the insider trading policy .

Board Governance (Committee Structure Overview)

CommitteeChairMembersFY2024 Meetings
AuditScott A. EstesDianne Hurley; Brian J. Flornes5
CompensationDianne HurleyMarvin R. O’Quinn; Valerie Richardson4
Nominating & Corporate GovernanceBrian J. FlornesWilbur H. Smith III; Valerie Richardson3

Insider Trades

  • Attempts to fetch Form 4 transactions for “Jeffrey Hanson” at AHR via the insider-trades skill failed due to API authorization (HTTP 401). No insider transaction table is included. If needed, we can re-run upon access restoration.

Governance Assessment

  • Positives

    • Separation of Chair and CEO roles; majority independent board; fully independent committees .
    • Attendance met thresholds; all directors attended the annual meeting .
    • Strong shareholder support on Say-on-Pay in 2024 (97.4% approval), signaling confidence in compensation governance .
    • Stock ownership guidelines and prohibition of hedging/pledging strengthen alignment and risk control .
    • Related party transaction policy with independent committee oversight; directors recuse where interested .
  • Red Flags and Watch Items

    • Chairman not independent and presides executive sessions in absence of a Lead Independent Director—may dampen independent board leadership optics .
    • Shared beneficial ownership of 1,268,643 OP Units through AHI Group Holdings (with CEO Prosky and director Streiff) creates potential related-party and influence interlock; continued robust Nominating & Governance Committee oversight is essential .
    • Historical ties to former adviser and co-sponsor (AHI) require ongoing monitoring of related-party exposure, notwithstanding established policies .
  • Overall Impression

    • Hanson offers extensive domain expertise and continuity benefits. Governance structures (independent committees, policies) mitigate risks, but absence of a Lead Independent Director and the OP Unit interlock argue for reinforcing independent leadership mechanisms and transparent conflict management .